Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

Kim, JinaJinaKimCHIA-HSIEN CHENGNam, Taek-KeunTaek-KeunNamKim, Jin HeeJin HeeKimJang, Byoung KukByoung KukJangHuang, Wen-YenWen-YenHuangAikata, HiroshiHiroshiAikataKim, MyungsooMyungsooKimKwon, Jung HyunJung HyunKwonYue, JinboJinboYueLee, Victor Ho FunVictor Ho FunLeeZeng, ZhaochongZhaochongZengSeong, JinsilJinsilSeong2023-08-292023-08-292023-06-132072-6694https://scholars.lib.ntu.edu.tw/handle/123456789/634809Although systemic treatment is the mainstay for advanced hepatocellular carcinoma (HCC), numerous studies have highlighted the added value of local treatment. This study aimed to investigate the clinical efficacy of liver-directed combined radiotherapy (LD combined RT) compared with that of sorafenib, a recommended treatment until recently for locally advanced HCC presenting portal vein tumor thrombosis (PVTT), using a multinational patient cohort.enhepatocellular carcinoma; portal vein tumor thrombosis; prognostic factors; radiotherapy; sorafenib[SDGs]SDG3Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosisjournal article10.3390/cancers15123164373707742-s2.0-85163825696https://api.elsevier.com/content/abstract/scopus_id/85163825696